Neuroprotective Products consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions.
The global Neuroprotective Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neuroprotective Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroprotective Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuroprotective Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuroprotective Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Genervon Biopharmaceuticals (Canada)
NeuroVive Pharmaceutical (Sweden)
Ceregene (USA)
BHRPharma (Thailand)
Neuren Pharmaceuticals (Australia)
Allon therapeutics (Canada)
Bionure Inc. (USA)
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Cholinesterase inhibitors
NMDA receptor antagonists
Others
Segment by Application
Alzheimer's disease
Multiple sclerosis
Others
The global Neuroprotective Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neuroprotective Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroprotective Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuroprotective Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuroprotective Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Genervon Biopharmaceuticals (Canada)
NeuroVive Pharmaceutical (Sweden)
Ceregene (USA)
BHRPharma (Thailand)
Neuren Pharmaceuticals (Australia)
Allon therapeutics (Canada)
Bionure Inc. (USA)
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Cholinesterase inhibitors
NMDA receptor antagonists
Others
Segment by Application
Alzheimer's disease
Multiple sclerosis
Others
Table of Contents
Executive Summary
1 Industry Overview of Neuroprotective Products
1.1 Definition of Neuroprotective Products
1.2 Neuroprotective Products Segment by Type
1.2.1 Global Neuroprotective Products Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cholinesterase inhibitors
1.2.3 NMDA receptor antagonists
1.2.4 Others
1.3 Neuroprotective Products Segment by Applications
1.3.1 Global Neuroprotective Products Consumption Comparison by Applications (2014-2025)
1.3.2 Alzheimer's disease
1.3.3 Multiple sclerosis
1.3.4 Others
1.4 Global Neuroprotective Products Overall Market
1.4.1 Global Neuroprotective Products Revenue (2014-2025)
1.4.2 Global Neuroprotective Products Production (2014-2025)
1.4.3 North America Neuroprotective Products Status and Prospect (2014-2025)
1.4.4 Europe Neuroprotective Products Status and Prospect (2014-2025)
1.4.5 China Neuroprotective Products Status and Prospect (2014-2025)
1.4.6 Japan Neuroprotective Products Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neuroprotective Products Status and Prospect (2014-2025)
1.4.8 India Neuroprotective Products Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroprotective Products
2.3 Manufacturing Process Analysis of Neuroprotective Products
2.4 Industry Chain Structure of Neuroprotective Products
3 Development and Manufacturing Plants Analysis of Neuroprotective Products
3.1 Capacity and Commercial Production Date
3.2 Global Neuroprotective Products Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neuroprotective Products
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Neuroprotective Products Production and Capacity Analysis
4.2 Neuroprotective Products Revenue Analysis
4.3 Neuroprotective Products Price Analysis
4.4 Market Concentration Degree
5 Neuroprotective Products Regional Market Analysis
5.1 Neuroprotective Products Production by Regions
5.1.1 Global Neuroprotective Products Production by Regions
5.1.2 Global Neuroprotective Products Revenue by Regions
5.2 Neuroprotective Products Consumption by Regions
5.3 North America Neuroprotective Products Market Analysis
5.3.1 North America Neuroprotective Products Production
5.3.2 North America Neuroprotective Products Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neuroprotective Products Import and Export
5.4 Europe Neuroprotective Products Market Analysis
5.4.1 Europe Neuroprotective Products Production
5.4.2 Europe Neuroprotective Products Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neuroprotective Products Import and Export
5.5 China Neuroprotective Products Market Analysis
5.5.1 China Neuroprotective Products Production
5.5.2 China Neuroprotective Products Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neuroprotective Products Import and Export
5.6 Japan Neuroprotective Products Market Analysis
5.6.1 Japan Neuroprotective Products Production
5.6.2 Japan Neuroprotective Products Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neuroprotective Products Import and Export
5.7 Southeast Asia Neuroprotective Products Market Analysis
5.7.1 Southeast Asia Neuroprotective Products Production
5.7.2 Southeast Asia Neuroprotective Products Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neuroprotective Products Import and Export
5.8 India Neuroprotective Products Market Analysis
5.8.1 India Neuroprotective Products Production
5.8.2 India Neuroprotective Products Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neuroprotective Products Import and Export
6 Neuroprotective Products Segment Market Analysis (by Type)
6.1 Global Neuroprotective Products Production by Type
6.2 Global Neuroprotective Products Revenue by Type
6.3 Neuroprotective Products Price by Type
7 Neuroprotective Products Segment Market Analysis (by Application)
7.1 Global Neuroprotective Products Consumption by Application
7.2 Global Neuroprotective Products Consumption Market Share by Application (2014-2019)
8 Neuroprotective Products Major Manufacturers Analysis
8.1 Genervon Biopharmaceuticals (Canada)
8.1.1 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production Sites and Area Served
8.1.2 Genervon Biopharmaceuticals (Canada) Product Introduction, Application and Specification
8.1.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 NeuroVive Pharmaceutical (Sweden)
8.2.1 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production Sites and Area Served
8.2.2 NeuroVive Pharmaceutical (Sweden) Product Introduction, Application and Specification
8.2.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Ceregene (USA)
8.3.1 Ceregene (USA) Neuroprotective Products Production Sites and Area Served
8.3.2 Ceregene (USA) Product Introduction, Application and Specification
8.3.3 Ceregene (USA) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BHRPharma (Thailand)
8.4.1 BHRPharma (Thailand) Neuroprotective Products Production Sites and Area Served
8.4.2 BHRPharma (Thailand) Product Introduction, Application and Specification
8.4.3 BHRPharma (Thailand) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Neuren Pharmaceuticals (Australia)
8.5.1 Neuren Pharmaceuticals (Australia) Neuroprotective Products Production Sites and Area Served
8.5.2 Neuren Pharmaceuticals (Australia) Product Introduction, Application and Specification
8.5.3 Neuren Pharmaceuticals (Australia) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allon therapeutics (Canada)
8.6.1 Allon therapeutics (Canada) Neuroprotective Products Production Sites and Area Served
8.6.2 Allon therapeutics (Canada) Product Introduction, Application and Specification
8.6.3 Allon therapeutics (Canada) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bionure Inc. (USA)
8.7.1 Bionure Inc. (USA) Neuroprotective Products Production Sites and Area Served
8.7.2 Bionure Inc. (USA) Product Introduction, Application and Specification
8.7.3 Bionure Inc. (USA) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Neuroprotective Products Market
9.1 Global Neuroprotective Products Market Trend Analysis
9.1.1 Global Neuroprotective Products Market Size (Volume and Value) Forecast 2019-2025
9.2 Neuroprotective Products Regional Market Trend
9.2.1 North America Neuroprotective Products Forecast 2019-2025
9.2.2 Europe Neuroprotective Products Forecast 2019-2025
9.2.3 China Neuroprotective Products Forecast 2019-2025
9.2.4 Japan Neuroprotective Products Forecast 2019-2025
9.2.5 Southeast Asia Neuroprotective Products Forecast 2019-2025
9.2.6 India Neuroprotective Products Forecast 2019-2025
9.3 Neuroprotective Products Market Trend (Product Type)
9.4 Neuroprotective Products Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neuroprotective Products Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Neuroprotective Products
1.1 Definition of Neuroprotective Products
1.2 Neuroprotective Products Segment by Type
1.2.1 Global Neuroprotective Products Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cholinesterase inhibitors
1.2.3 NMDA receptor antagonists
1.2.4 Others
1.3 Neuroprotective Products Segment by Applications
1.3.1 Global Neuroprotective Products Consumption Comparison by Applications (2014-2025)
1.3.2 Alzheimer's disease
1.3.3 Multiple sclerosis
1.3.4 Others
1.4 Global Neuroprotective Products Overall Market
1.4.1 Global Neuroprotective Products Revenue (2014-2025)
1.4.2 Global Neuroprotective Products Production (2014-2025)
1.4.3 North America Neuroprotective Products Status and Prospect (2014-2025)
1.4.4 Europe Neuroprotective Products Status and Prospect (2014-2025)
1.4.5 China Neuroprotective Products Status and Prospect (2014-2025)
1.4.6 Japan Neuroprotective Products Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neuroprotective Products Status and Prospect (2014-2025)
1.4.8 India Neuroprotective Products Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroprotective Products
2.3 Manufacturing Process Analysis of Neuroprotective Products
2.4 Industry Chain Structure of Neuroprotective Products
3 Development and Manufacturing Plants Analysis of Neuroprotective Products
3.1 Capacity and Commercial Production Date
3.2 Global Neuroprotective Products Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neuroprotective Products
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Neuroprotective Products Production and Capacity Analysis
4.2 Neuroprotective Products Revenue Analysis
4.3 Neuroprotective Products Price Analysis
4.4 Market Concentration Degree
5 Neuroprotective Products Regional Market Analysis
5.1 Neuroprotective Products Production by Regions
5.1.1 Global Neuroprotective Products Production by Regions
5.1.2 Global Neuroprotective Products Revenue by Regions
5.2 Neuroprotective Products Consumption by Regions
5.3 North America Neuroprotective Products Market Analysis
5.3.1 North America Neuroprotective Products Production
5.3.2 North America Neuroprotective Products Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neuroprotective Products Import and Export
5.4 Europe Neuroprotective Products Market Analysis
5.4.1 Europe Neuroprotective Products Production
5.4.2 Europe Neuroprotective Products Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neuroprotective Products Import and Export
5.5 China Neuroprotective Products Market Analysis
5.5.1 China Neuroprotective Products Production
5.5.2 China Neuroprotective Products Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neuroprotective Products Import and Export
5.6 Japan Neuroprotective Products Market Analysis
5.6.1 Japan Neuroprotective Products Production
5.6.2 Japan Neuroprotective Products Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neuroprotective Products Import and Export
5.7 Southeast Asia Neuroprotective Products Market Analysis
5.7.1 Southeast Asia Neuroprotective Products Production
5.7.2 Southeast Asia Neuroprotective Products Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neuroprotective Products Import and Export
5.8 India Neuroprotective Products Market Analysis
5.8.1 India Neuroprotective Products Production
5.8.2 India Neuroprotective Products Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neuroprotective Products Import and Export
6 Neuroprotective Products Segment Market Analysis (by Type)
6.1 Global Neuroprotective Products Production by Type
6.2 Global Neuroprotective Products Revenue by Type
6.3 Neuroprotective Products Price by Type
7 Neuroprotective Products Segment Market Analysis (by Application)
7.1 Global Neuroprotective Products Consumption by Application
7.2 Global Neuroprotective Products Consumption Market Share by Application (2014-2019)
8 Neuroprotective Products Major Manufacturers Analysis
8.1 Genervon Biopharmaceuticals (Canada)
8.1.1 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production Sites and Area Served
8.1.2 Genervon Biopharmaceuticals (Canada) Product Introduction, Application and Specification
8.1.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 NeuroVive Pharmaceutical (Sweden)
8.2.1 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production Sites and Area Served
8.2.2 NeuroVive Pharmaceutical (Sweden) Product Introduction, Application and Specification
8.2.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Ceregene (USA)
8.3.1 Ceregene (USA) Neuroprotective Products Production Sites and Area Served
8.3.2 Ceregene (USA) Product Introduction, Application and Specification
8.3.3 Ceregene (USA) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BHRPharma (Thailand)
8.4.1 BHRPharma (Thailand) Neuroprotective Products Production Sites and Area Served
8.4.2 BHRPharma (Thailand) Product Introduction, Application and Specification
8.4.3 BHRPharma (Thailand) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Neuren Pharmaceuticals (Australia)
8.5.1 Neuren Pharmaceuticals (Australia) Neuroprotective Products Production Sites and Area Served
8.5.2 Neuren Pharmaceuticals (Australia) Product Introduction, Application and Specification
8.5.3 Neuren Pharmaceuticals (Australia) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allon therapeutics (Canada)
8.6.1 Allon therapeutics (Canada) Neuroprotective Products Production Sites and Area Served
8.6.2 Allon therapeutics (Canada) Product Introduction, Application and Specification
8.6.3 Allon therapeutics (Canada) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bionure Inc. (USA)
8.7.1 Bionure Inc. (USA) Neuroprotective Products Production Sites and Area Served
8.7.2 Bionure Inc. (USA) Product Introduction, Application and Specification
8.7.3 Bionure Inc. (USA) Neuroprotective Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Neuroprotective Products Market
9.1 Global Neuroprotective Products Market Trend Analysis
9.1.1 Global Neuroprotective Products Market Size (Volume and Value) Forecast 2019-2025
9.2 Neuroprotective Products Regional Market Trend
9.2.1 North America Neuroprotective Products Forecast 2019-2025
9.2.2 Europe Neuroprotective Products Forecast 2019-2025
9.2.3 China Neuroprotective Products Forecast 2019-2025
9.2.4 Japan Neuroprotective Products Forecast 2019-2025
9.2.5 Southeast Asia Neuroprotective Products Forecast 2019-2025
9.2.6 India Neuroprotective Products Forecast 2019-2025
9.3 Neuroprotective Products Market Trend (Product Type)
9.4 Neuroprotective Products Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neuroprotective Products Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
